Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial

Pediatrics
W RobertsG Koren

Abstract

Anecdotal reports on the efficacy of secretin in autism raised great hopes for the treatment of children with this disorder. Initial single-dose, randomized, controlled trials failed to demonstrate any therapeutic effects of secretin. The present study is the first to test the outcome of repeated doses and to examine whether there is a subgroup of children who are more likely to achieve positive effects. Sixty-four children with autism (ages 2-7 years; 55 boys and 9 girls) with a range of intelligence quotient and verbal ability were randomly assigned, in a double-blind manner, to secretin or placebo groups. Children received 2 doses of placebo or porcine secretin, 6 weeks apart. Assessments were performed at baseline and 3 weeks after each injection using several outcome measures. There were no group differences on formal measures of language, cognition, or autistic symptomatology. Subgroupings based on cognitive level, the presence or absence of diarrhea, or a history of regression failed to show any significant therapeutic effects of secretin. No evidence is provided for the efficacy of repeated doses of porcine secretin in the treatment of children with autism. The possible relationship between relief of biological symptoms...Continue Reading

Citations

Oct 27, 2009·Applied Psychophysiology and Biofeedback·Robert CobenThomas E Myers
Jan 5, 2005·Journal of Autism and Developmental Disorders·Barbara E Esch, James E Carr
Nov 4, 2005·Journal of Autism and Developmental Disorders·Craig A EricksonChristopher J McDougle
Jul 18, 2006·Journal of Autism and Developmental Disorders·Cindy K SchneiderJames A Ostrem
Apr 6, 2004·Schizophrenia Research·Brian B SheitmanJeffrey A Lieberman
Oct 10, 2003·Current Problems in Pediatric and Adolescent Health Care·Patricia Manning-CourtneyBridget Kent
Nov 9, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·T OwleyP A Filipek
Nov 1, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Alan S UnisGeraldine Dawson
Nov 17, 2005·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Stefano PallantiValentina Cesarali
Apr 6, 2011·Pediatrics·Shanthi KrishnaswamiJeremy Veenstra-Vanderweele
Jul 20, 2002·Pharmacotherapy·Nick C PatelM Lynn Crismon
Jan 9, 2007·Biological Psychiatry·Susan E LevyJennifer A Pinto-Martin
May 21, 2013·Journal of Paediatrics and Child Health·Andrew J O Whitehouse
Jul 5, 2005·Biological Psychiatry·Karyn M MyersMichael Davis
Mar 5, 2004·Expert Opinion on Pharmacotherapy·Janet K KernMadhukar H Trivedi
Jun 7, 2005·Autism : the International Journal of Research and Practice·Karen Ratliff-SchaubMary A M Rogers
Jun 25, 2005·Mental Retardation and Developmental Disabilities Research Reviews·Susan E Levy, Susan L Hyman
Apr 20, 2012·The Cochrane Database of Systematic Reviews·Katrina WilliamsDanielle M Wheeler
Apr 21, 2004·CNS Spectrums·Thomas Owley
Nov 1, 2002·Paediatrics & Child Health·Wendy Roberts, Mary Harford
Jul 1, 2002·Expert Review of Neurotherapeutics·Kimberly A StiglerChristopher J McDougle
May 30, 2003·Experimental Biology and Medicine·John F White

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.